Novel Antigens and Clinical Updates in Membranous Nephropathy.
Annu Rev Med
; 75: 219-332, 2024 Jan 29.
Article
em En
| MEDLINE
| ID: mdl-37552894
ABSTRACT
Membranous nephropathy (MN), an autoimmune kidney disease and leading cause of nephrotic syndrome, leads to kidney failure in up to one-third of affected individuals. Most MN cases are due to an autoimmune reaction against the phospholipase A2 receptor (PLA2R) located on kidney podocytes. Serum PLA2R antibody quantification is now part of routine clinical practice because antibody titers correlate with disease activity and treatment response. Recent advances in target antigen detection have led to the discovery of more than 20 other podocyte antigens, yet the clinical impact of additional antigen detection remains unknown and is under active investigation. Here we review recent findings and hypothesize how current research will inform future care of patients with MN.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Glomerulonefrite Membranosa
Limite:
Humans
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article